Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 30 6 2021
medline: 28 10 2021
entrez: 29 6 2021
Statut: ppublish

Résumé

Radical cystectomy (RC) for the management of muscle-invasive bladder cancer remains a morbid procedure with high rates of perioperative complications. The role of preoperative immunonutritional supplementation (pre-INS) in improving post-RC outcomes is promising and needs further validation. We performed a retrospective review of 204 patients who underwent RC for bladder cancer at a single institution, comparing patients who received oral L-arginine-based pre-INS, and those who did not. Preoperative features, postoperative complications, and readmission data were collected. Outcomes of interest included development of high-grade (Clavien-Dindo III-V) complications, readmission within 30 days, ileus, total parenteral nutrition (TPN) requirement, postoperative infection, and length of stay (LOS). Categorical and continuous outcomes were assessed using Fisher's exact test and Welch T-test, respectively. Multivariable logistic regression (MLoR) analysis was used to identify predictive factors for our outcomes. Patients who received pre-INS had significantly lower odds of requiring postoperative TPN (17.3% vs 35.6%; Fisher p=0.015, OR=0.38) and developing postoperative infection (25% vs 45%; Fisher p=0.003; OR=0.41) but no significant difference in the rates of other outcomes. On MLoR, when adjusting for age, gender, body mass index, Charlson comorbidity index, undergoing neoadjuvant chemotherapy and operative features, pre-INS was a significant predictor of postoperative infection (Fisher p=0.02; OR=0.35) but not for high-grade complications, readmission, ileus, needing TPN or LOS. Preoperative immunonutrition with an L-arginine-based supplement is associated with significant reduction in postoperative infection, one of the most common complications of RC.

Identifiants

pubmed: 34184927
doi: 10.1097/JU.0000000000001945
doi:

Substances chimiques

Arginine 94ZLA3W45F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1132-1138

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Sari Khaleel (S)

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Subodh Regmi (S)

Department of Urology, University of Minnesota, Minneapolis, Minnesota.

Peter Hannah (P)

Department of Urology, University of Minnesota, Minneapolis, Minnesota.

Bradly Watarai (B)

Department of Urology, University of Minnesota, Minneapolis, Minnesota.

Niranjan Sathianathen (N)

Peter MacCallum Cancer Centre, Melbourne, Australia.

Christopher Weight (C)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.

Badrinath Konety (B)

Rush Medical College, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH